[
  {
    "ts": "2026-02-12T05:37:12+00:00",
    "headline": "5 Revealing Analyst Questions From Cigna’s Q4 Earnings Call",
    "summary": "Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the quarter’s performance to robust expansion in its EverNorth specialty and care services, successful adoption of biosimilars, and operational discipline across its health benefits business. CEO David Cordani highlighted the company’s strategic investments, including the new pharmacy benefits model and expand",
    "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cigna-053712739.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2b2f72eb-9640-3206-8dba-1bc4b7e4b8ef",
      "content": {
        "id": "2b2f72eb-9640-3206-8dba-1bc4b7e4b8ef",
        "contentType": "STORY",
        "title": "5 Revealing Analyst Questions From Cigna’s Q4 Earnings Call",
        "description": "",
        "summary": "Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the quarter’s performance to robust expansion in its EverNorth specialty and care services, successful adoption of biosimilars, and operational discipline across its health benefits business. CEO David Cordani highlighted the company’s strategic investments, including the new pharmacy benefits model and expand",
        "pubDate": "2026-02-12T05:37:12Z",
        "displayTime": "2026-02-12T05:37:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/94a8082c27be7c4d5dba343598b8fc7c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CI Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t4Br6nlGMzqWR3qqmoPjEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/94a8082c27be7c4d5dba343598b8fc7c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DHXwLUc6A.eAaebU3RZGJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/94a8082c27be7c4d5dba343598b8fc7c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cigna-053712739.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cigna-053712739.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]